speb/financial-data huggingface dataset:
Financial ratios for 1167.HK — annual report dated 2023-12-31
Total revenue: 8933895.921237692
Gross profit: 450492.264416315
Operating income: -57416033.75527426
Net income: -50509001.40646976
Capital expenditures: 5077355.836849508
Operating cash flow: -51223488.04500703
Depreciation & amortization: 3527426.1603375524
Net tangible assets: 150774261.60337552
Owner earnings: -52058931.08298172
Return on net tangible assets (%): -34.5277307475245
Buffett classification: The Gruesome
Stock price: 0.46350832266325226
Shares outstanding: 782374980
Book value: 150966385.3727145
P/B ratio: 2.402106361480376
Market cap (USD): 362637314.67349553
Debt to equity: 0.1955651866875479
Current ratio: 5.695948910447033
Quick ratio: 5.695948910447033
Interest coverage ratio: -49.11308950914341
COGS to revenue (%): 94.95749370277079
R&D to revenue (%): 586.1460957178842
SG&A to revenue (%): 24.73551637279597
Free cash flow (dilution-adjusted): -58750492.26441631
Buyback yield (%): 0.22037338293853978
Retained earnings: -449198171.5893108
Receivables turnover: 6.8015847521147865
Capitalized R&D asset: 95265608.86197197
ROCI (R&D-adjusted, %): -16.13115594210991
Rosenberg metric: -0.02131412045781178
FCF margin (%): -657.6133501259446
Revenue growth (%): -35.05742734755046
Rule of 40 score: -692.670777473495
Financial ratios for 1167.HK — annual report dated 2024-12-31
Total revenue: 21329863.01369863
Gross profit: 21329863.01369863
Operating income: -27835068.493150685
Net income: -21330000
Capital expenditures: 1620821.9178082193
Operating cash flow: -10153424.657534247
Depreciation & amortization: 3624383.5616438356
Net tangible assets: 126347671.23287672
Owner earnings: -19326438.356164385
Return on net tangible assets (%): -15.296236303827882
Buffett classification: The Gruesome
Stock price: 0.163659793814433
Shares outstanding: 782374980
Book value: 126463013.69863012
P/B ratio: 1.0124962561583974
Market cap (USD): 128043327.91237113
Debt to equity: 0.16473385471955634
Current ratio: 4.894517513156486
Quick ratio: 4.894517513156486
Interest coverage ratio: -24.19288010477438
COGS to revenue (%): 0
R&D to revenue (%): 212.048834998844
SG&A to revenue (%): 7.678475094407481
Free cash flow (dilution-adjusted): -13174520.547945205
Buyback yield (%): 0.4883834838949122
Retained earnings: -458836712.3287671
Receivables turnover: 20.279760354258922
Capitalized R&D asset: 101444547.71491846
ROCI (R&D-adjusted, %): -14.341729130269313
Rosenberg metric: 0.3987224055312561
FCF margin (%): -61.765612556837155
Revenue growth (%): 138.7520875746179
Rule of 40 score: 76.98647501778073
Financial ratios for 1167.HK — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 126347671.23287672
Buffett classification: The Gruesome
Stock price: 0.163659793814433
Shares outstanding: 782374980
Book value: 126463013.69863012
P/B ratio: 1.0124962561583974
Market cap (USD): 128043327.91237113
Debt to equity: 0.16473385471955634
Current ratio: 4.894517513156486
Quick ratio: 4.894517513156486
Buyback yield (%): 0
Retained earnings: -458836712.3287671
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 1167.HK — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 120802092.05020921
Buffett classification: The Gruesome
Stock price: 0.5528662420382165
Shares outstanding: 782374980
Book value: 120972942.81729427
P/B ratio: 3.5755823160440445
Market cap (USD): 432548715.0573248
Debt to equity: 0.16487774621386805
Current ratio: 7.529883818421368
Quick ratio: 7.529883818421368
Buyback yield (%): 0
Retained earnings: -475383821.4783822
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 1186.HK — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.5102564102564102
Shares outstanding: 2076296000
Market cap (USD): 1059443343.5897435
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 1186.HK — annual report dated 2022-12-31
Total revenue: 157516216522.9885
Gross profit: 15885803591.954023
Operating income: 7754472270.114943
Net income: 4568145114.942529
Capital expenditures: 3992907040.229885
Operating cash flow: 8065366666.666667
Depreciation & amortization: 2948418247.1264367
Net tangible assets: 32709485344.827587
Owner earnings: 3523656321.839081
Return on net tangible assets (%): 10.772582584813684
Capex to operating income (%): 51.4916670166995
Buffett classification: The Good
Stock price: 0.49679075738125805
P/E ratio: 0.22579945173231508
Shares outstanding: 2076296000
Book value: 55448283333.33334
P/B ratio: 0.018602643767829476
Market cap (USD): 1031484662.3876766
Debt to equity: 0.6759399301697854
Current ratio: 1.080688638330512
Quick ratio: 0.7599027604654963
Effective tax rate (%): 15.942518891610408
Interest coverage ratio: 8.785531376812314
COGS to revenue (%): 89.91481388861598
R&D to revenue (%): 2.280729958813847
SG&A to revenue (%): 0.7194287540912353
Free cash flow (dilution-adjusted): 3717623275.862069
Buyback yield (%): 0
Retained earnings: 23273151149.42529
Inventory turnover: 3.287814422781867
Receivables turnover: 7.762627094533193
Capitalized R&D asset: 3592519540.229885
ROCI (R&D-adjusted, %): 11.499710411633098
FCF margin (%): 2.360152724541543
Rule of 40 score: 2.360152724541543
Financial ratios for 1186.HK — annual report dated 2023-12-31
Total revenue: 160055342616.03375
Gross profit: 16630722222.222221
Operating income: 8072919549.929676
Net income: 4546937974.683544
Capital expenditures: 4369140506.329114
Operating cash flow: 2870892827.004219
Depreciation & amortization: 2996618706.0478196
Net tangible assets: 33759489451.47679
Owner earnings: 3174416174.4022493
Return on net tangible assets (%): 9.403033712831773
Capex to operating income (%): 54.120946942511935
Buffett classification: The Good
Stock price: 0.5198463508322663
P/E ratio: 0.23738060753352402
Shares outstanding: 2076296000
Book value: 58666634739.8031
P/B ratio: 0.018398104879115036
Market cap (USD): 1079354898.8476312
Debt to equity: 0.8080214169084714
Current ratio: 1.066830346041907
Quick ratio: 0.7585872323917295
Effective tax rate (%): 16.738944979920756
Interest coverage ratio: 7.69510194943351
COGS to revenue (%): 89.60939263232302
R&D to revenue (%): 2.348471615065115
SG&A to revenue (%): 0.8113216036458051
Free cash flow (dilution-adjusted): -2040588466.9479606
Buyback yield (%): 0
Retained earnings: 25573149789.029533
Inventory turnover: 3.3147178400331248
Receivables turnover: 7.303769337120798
Capitalized R&D asset: 6165842381.686794
ROCI (R&D-adjusted, %): 9.410350648697897
Rosenberg metric: 0.20735270105741185
FCF margin (%): -1.2749268056882357
Revenue growth (%): 1.6119775786226354
Rule of 40 score: 0.33705077293439967
Financial ratios for 1186.HK — annual report dated 2024-12-31
Total revenue: 146187854383.56165
Gross profit: 15009527260.273973
Operating income: 7096342054.79452
Net income: 3709366712.3287673
Capital expenditures: 4820401369.863014
Operating cash flow: -4304634520.547945
Depreciation & amortization: 3236417808.219178
Net tangible assets: 28924644109.589043
Owner earnings: 2125383150.6849308
Return on net tangible assets (%): 7.348001042406353
Capex to operating income (%): 67.92797377356118
Buffett classification: The Good
Stock price: 0.6984536082474226
P/E ratio: 0.3909552614923982
Shares outstanding: 2076296000
Book value: 57889975616.438354
P/B ratio: 0.025050907649335666
Market cap (USD): 1450196432.9896905
Debt to equity: 1.179918797401652
Current ratio: 1.0280568804314159
Quick ratio: 0.7709324255273485
Effective tax rate (%): 16.617029578309694
Interest coverage ratio: 5.376431266960497
COGS to revenue (%): 89.7327125269295
R&D to revenue (%): 2.409479069432691
SG&A to revenue (%): 0.8200105921697932
Free cash flow (dilution-adjusted): -9503090821.917809
Buyback yield (%): 0
Retained earnings: 26993968904.10959
Inventory turnover: 3.34689632810159
Receivables turnover: 5.211834872134072
Capitalized R&D asset: 7226329575.821476
ROCI (R&D-adjusted, %): 6.359562372715555
Rosenberg metric: -0.431300294447834
FCF margin (%): -6.500602161506517
Revenue growth (%): -8.664183279242135
Rule of 40 score: -15.164785440748652
Financial ratios for 1186.HK — quarterly report dated 2024-12-31
Total revenue: 42335098219.178085
Gross profit: 5498090684.931507
Operating income: 2534821506.849315
Net income: 974967534.2465754
Capital expenditures: 1492977397.260274
Net tangible assets: 28924644109.589043
Owner earnings: -518009863.0136986
Return on net tangible assets (%): -1.7908945086794308
Capex to operating income (%): 58.898719031147365
Buffett classification: The Good
Stock price: 0.6984536082474226
P/E ratio: 0.3718576214207885
Shares outstanding: 2076296000
Book value: 57889975616.438354
P/B ratio: 0.025050907649335666
Market cap (USD): 1450196432.9896905
Debt to equity: 1.179918797401652
Current ratio: 1.0280568804314159
Quick ratio: 0.7709324255273485
Effective tax rate (%): 18.361783301845037
Interest coverage ratio: 6.832847018821886
COGS to revenue (%): 87.01292564276882
R&D to revenue (%): 3.427612899723668
SG&A to revenue (%): -3.1558962587139514
Free cash flow (dilution-adjusted): 6164857534.246575
Buyback yield (%): 0
Retained earnings: 26993968904.10959
Inventory turnover: 0.9398629175896333
Receivables turnover: 1.5093151352712106
Capitalized R&D asset: 1451083287.671233
ROCI (R&D-adjusted, %): 3.360953314252599
FCF margin (%): 14.562048497749448
Rule of 40 score: 14.562048497749448
Financial ratios for 1186.HK — quarterly report dated 2025-03-31
Total revenue: 35366668319.55923
Gross profit: 2654862809.9173555
Operating income: 1283523966.9421487
Net income: 840359504.1322315
Capital expenditures: 792259090.9090909
Net tangible assets: 28858238842.97521
Owner earnings: 48100413.2231406
Return on net tangible assets (%): 0.16667826988634615
Capex to operating income (%): 61.72530558946702
Buffett classification: The Good
Stock price: 0.6015424164524421
P/E ratio: 0.37156125056271494
Shares outstanding: 2076296000
Book value: 58897054683.19559
P/B ratio: 0.021206155720837713
Market cap (USD): 1248980113.1105397
Debt to equity: 1.2626154136800731
Current ratio: 1.0312229439301202
Quick ratio: 0.772179798135666
Effective tax rate (%): 17.88293094330567
Interest coverage ratio: 3.42621657296864
COGS to revenue (%): 92.49331945568335
R&D to revenue (%): 1.1451261723249
SG&A to revenue (%): 2.481052376237027
Free cash flow (dilution-adjusted): -6173985123.966943
Buyback yield (%): 0
Retained earnings: 27771972865.013775
Inventory turnover: 0.8087638605334373
Receivables turnover: 1.1913503593454977
Capitalized R&D asset: 1377218777.9463377
ROCI (R&D-adjusted, %): 0.990442282982469
Rosenberg metric: -1.9593829652446058
FCF margin (%): -17.45707305019872
Revenue growth (%): -16.460171802464632
Rule of 40 score: -33.91724485266335
Financial ratios for 1186.HK — quarterly report dated 2025-06-30
Total revenue: 32417996234.309624
Gross profit: 3345468619.246862
Operating income: 1858791771.2691772
Net income: 901107531.3807532
Capital expenditures: 1898091213.3891213
Net tangible assets: 29696976290.09763
Owner earnings: -996983682.0083681
Return on net tangible assets (%): -3.3571892042787184
Capex to operating income (%): 102.11424661586008
Buffett classification: The Gruesome
Stock price: 0.6522292993630574
P/E ratio: 0.3757101783610849
Shares outstanding: 2076296000
Book value: 60054262482.56625
P/B ratio: 0.022549957810962192
Market cap (USD): 1354221085.3503187
Debt to equity: 1.4290429049495919
Current ratio: 1.0406387130438195
Quick ratio: 0.796515831605727
Effective tax rate (%): 18.46163553999625
Interest coverage ratio: 4.333204364437488
COGS to revenue (%): 89.68021158659344
R&D to revenue (%): 1.968802880047088
SG&A to revenue (%): -1.4071178580222197
Free cash flow (dilution-adjusted): -7684062482.566248
Buyback yield (%): 0
Retained earnings: 28243038912.133892
Inventory turnover: 0.7114934100306648
Receivables turnover: 0.9601957867670575
Capitalized R&D asset: 1388449221.834581
ROCI (R&D-adjusted, %): 1.4626666196129459
Rosenberg metric: 1.705229106695459
FCF margin (%): -23.703076609139128
Revenue growth (%): -8.337432462132336
Rule of 40 score: -32.040509071271465
Financial ratios for 1186.HK — quarterly report dated 2025-12-31
Total revenue: 43054459000
Gross profit: 5174157142.857142
Operating income: 2184289428.571429
Net income: 636869285.7142857
Capital expenditures: 2362627428.571429
Net tangible assets: 24280399142.857143
Owner earnings: -1725758142.857143
Return on net tangible assets (%): -7.107618506200835
Capex to operating income (%): 108.16457735258265
Buffett classification: The Gruesome
Stock price: 0.6902313624678663
P/E ratio: 0.42737690311815485
Shares outstanding: 2076296000
Book value: 60993550714.285736
P/B ratio: 0.023496330352692822
Market cap (USD): 1433124616.9665809
Debt to equity: 1.4938778269660378
Current ratio: 1.027502681974385
Quick ratio: 0.8079764893907135
Effective tax rate (%): 31.145363760386115
Interest coverage ratio: 3.752011825810755
COGS to revenue (%): 87.98229669345714
R&D to revenue (%): 3.456195857835372
SG&A to revenue (%): -3.086209623822836
Free cash flow (dilution-adjusted): 9283929428.571428
Buyback yield (%): 0
Retained earnings: 29855441857.142857
Inventory turnover: 0.9971253491833436
Receivables turnover: 1.2504201781572315
Capitalized R&D asset: 2049319227.544422
ROCI (R&D-adjusted, %): 2.2327376466394733
Rosenberg metric: 2.865176206137875
FCF margin (%): 21.563223982378755
Revenue growth (%): 32.81036461603775
Rule of 40 score: 54.373588598416504
Financial ratios for 1186.HK — annual report dated 2025-12-31
Total revenue: 147112065714.2857
Gross profit: 14302498857.142857
Operating income: 6678811000
Net income: 3098120714.285714
Capital expenditures: 6415422428.571428
Operating cash flow: 422425285.71428573
Depreciation & amortization: 3934753857.142857
Net tangible assets: 24280399142.857143
Owner earnings: 617452142.8571434
Return on net tangible assets (%): 2.5430065594238256
Capex to operating income (%): 96.05635536881383
Buffett classification: The Gruesome
Stock price: 0.6902313624678663
P/E ratio: 0.4625786885444179
Shares outstanding: 2076296000
Book value: 60993550714.285736
P/B ratio: 0.023496330352692822
Market cap (USD): 1433124616.9665809
Debt to equity: 1.4938778269660378
Current ratio: 1.027502681974385
Quick ratio: 0.8079764893907135
Effective tax rate (%): 19.478470575309963
Interest coverage ratio: 3.576300131618423
COGS to revenue (%): 90.2778206616169
R&D to revenue (%): 2.291349978227483
SG&A to revenue (%): 0.720547482334313
Free cash flow (dilution-adjusted): -6377652714.285714
Buyback yield (%): 0
Retained earnings: 29855441857.142857
Inventory turnover: 3.4959538133233243
Receivables turnover: 4.272539934122398
Capitalized R&D asset: 6971259256.120621
ROCI (R&D-adjusted, %): 4.9381177542263766
Rosenberg metric: -0.20072543643251725
FCF margin (%): -4.335234287765422
Revenue growth (%): 0.6322080138744992
Rule of 40 score: -3.7030262738909228
Financial ratios for 1244.HK — annual report dated 2022-12-31
Total revenue: 81521839.08045977
Gross profit: 75456465.51724137
Operating income: -46173132.183908045
Net income: -147176724.13793105
Capital expenditures: 7756034.482758621
Operating cash flow: -40054454.022988506
Depreciation & amortization: 3103448.275862069
Net tangible assets: 135369683.90804598
Owner earnings: -151829310.3448276
Return on net tangible assets (%): -112.1590196280301
Buffett classification: The Gruesome
Stock price: 5.455712451861361
Shares outstanding: 245920817
Book value: 128651436.7816092
P/B ratio: 10.428746829748674
Market cap (USD): 1341673263.4788191
Debt to equity: 0.19622319954791861
Current ratio: 3.0380359814909808
Quick ratio: 3.0348572355009584
Interest coverage ratio: -103.23321554770318
COGS to revenue (%): 7.440182448818453
R&D to revenue (%): 61.83802380012408
SG&A to revenue (%): 88.20868112345609
Free cash flow (dilution-adjusted): -68168821.83908045
Buyback yield (%): 0.0003962285079929905
Retained earnings: -522424568.9655172
Inventory turnover: 35.296822742474916
Receivables turnover: 7.270434771466281
Capitalized R&D asset: 50411494.25287356
ROCI (R&D-adjusted, %): -6.6929776629488416
FCF margin (%): -83.6203189329423
Rule of 40 score: -83.6203189329423
Financial ratios for 1244.HK — annual report dated 2023-12-31
Total revenue: 89303656.82137834
Gross profit: 82399156.11814345
Operating income: -59266947.960618846
Net income: -73797046.41350211
Capital expenditures: 889451.4767932489
Operating cash flow: -20311251.7580872
Depreciation & amortization: 3581012.658227848
Net tangible assets: 131647257.38396624
Owner earnings: -71105485.23206751
Return on net tangible assets (%): -54.012128049640395
Buffett classification: The Gruesome
Stock price: 0.9782330345710627
Shares outstanding: 245920817
Book value: 122459212.37693389
P/B ratio: 1.9644734145245717
Market cap (USD): 240567867.07810497
Debt to equity: 0.3243710411917054
Current ratio: 2.188683996474616
Quick ratio: 2.179466835607979
Interest coverage ratio: -54.21873391662378
COGS to revenue (%): 7.731487095813995
R&D to revenue (%): 67.01278370388803
SG&A to revenue (%): 93.84785234719638
Free cash flow (dilution-adjusted): -63248945.14767932
Buyback yield (%): 0.33628822348377185
Retained earnings: -585200000
Inventory turnover: 10.644189071986123
Receivables turnover: 116.31232826525003
Capitalized R&D asset: 93620567.534798
ROCI (R&D-adjusted, %): -16.133867751102777
Rosenberg metric: 0.1377203890461218
FCF margin (%): -70.8245859116244
Revenue growth (%): 9.545684725338601
Rule of 40 score: -61.27890118628579
Financial ratios for 1244.HK — annual report dated 2024-12-31
Total revenue: 61047534.24657534
Gross profit: 56037671.23287671
Operating income: -10878767.123287672
Net income: -25022328.76712329
Capital expenditures: 6209041.095890411
Operating cash flow: -28846301.369863015
Depreciation & amortization: 3459041.095890411
Net tangible assets: 107457123.28767124
Owner earnings: -27772328.76712329
Return on net tangible assets (%): -25.845032806968565
Buffett classification: The Gruesome
Stock price: 0.38917525773195877
Shares outstanding: 245920817
Book value: 96399178.08219178
P/B ratio: 0.9928123791265923
Market cap (USD): 95706297.33762887
Debt to equity: 0.337665585735114
Current ratio: 2.0249596136026304
Quick ratio: 2.0166383756877986
Interest coverage ratio: -8.356834683784069
COGS to revenue (%): 8.206495275408564
R&D to revenue (%): 40.55250007292768
SG&A to revenue (%): 70.50266242115396
Free cash flow (dilution-adjusted): -39535205.47945206
Buyback yield (%): 0.0379299699945043
Retained earnings: -594991095.890411
Inventory turnover: 9.010101010101009
Receivables turnover: 9.311081860348501
Capitalized R&D asset: 81488154.95151101
ROCI (R&D-adjusted, %): -17.170664005082557
Rosenberg metric: -0.44049701298539484
FCF margin (%): -64.76134698539427
Revenue growth (%): -31.640498923039377
Rule of 40 score: -96.40184590843364
Financial ratios for 1244.HK — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 107457123.28767124
Buffett classification: The Gruesome
Stock price: 0.38917525773195877
Shares outstanding: 245920817
Book value: 96399178.08219178
P/B ratio: 0.9928123791265923
Market cap (USD): 95706297.33762887
Debt to equity: 0.337665585735114
Current ratio: 2.0249596136026304
Quick ratio: 2.0166383756877986
Buyback yield (%): 0
Retained earnings: -594991095.890411
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 1293.HK — annual report dated 2021-12-31
Total revenue: 5899944113.029827
Gross profit: 358837048.6656201
Operating income: 71619152.27629513
Net income: 86654003.13971743
Capital expenditures: 35756985.87127159
Operating cash flow: 237418053.37519622
Depreciation & amortization: 84228100.4709576
Net tangible assets: 959437362.6373626
Owner earnings: 135125117.73940346
Return on net tangible assets (%): 14.083787332188411
Capex to operating income (%): 49.92656954850137
Buffett classification: The Good
Stock price: 0.08717948717948719
P/E ratio: 2.8547185621338222
Shares outstanding: 2837511429
Book value: 1361796703.2967033
P/B ratio: 0.1816517771318596
Market cap (USD): 247372791.24615386
Debt to equity: 1.6143105568008835
Current ratio: 1.342507444463399
Quick ratio: 1.14978420354579
Effective tax rate (%): 40.23012149578972
Interest coverage ratio: 0.7628894596727802
COGS to revenue (%): 93.91795851297744
SG&A to revenue (%): 5.102528177634335
Free cash flow (dilution-adjusted): 149375196.23233908
Buyback yield (%): 0
Retained earnings: 813710675.0392464
Inventory turnover: 12.68520596969439
Receivables turnover: 99.69109076874514
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.340573705790745
FCF margin (%): 2.5318069691956744
Rule of 40 score: 2.5318069691956744
Financial ratios for 1293.HK — annual report dated 2022-12-31
Total revenue: 4554409051.724138
Gross profit: 66580459.77011494
Operating income: -177444396.55172414
Net income: -100284770.11494254
Capital expenditures: 36642672.4137931
Operating cash flow: 111521264.36781609
Depreciation & amortization: 76663793.10344827
Net tangible assets: 743432183.908046
Owner earnings: -60263649.425287366
Return on net tangible assets (%): -8.106139434063198
Buffett classification: The Gruesome
Stock price: 0.05648267008985879
Shares outstanding: 2837511429
Book value: 1102603304.597701
P/B ratio: 0.14535619587943047
Market cap (USD): 160270221.92041078
Debt to equity: 1.6905273426174392
Current ratio: 1.2220252017911772
Quick ratio: 0.9851264683489911
Interest coverage ratio: -2.386277214867027
COGS to revenue (%): 98.53810979615653
SG&A to revenue (%): 5.6370631376624525
Free cash flow (dilution-adjusted): 32447126.436781608
Buyback yield (%): 0
Retained earnings: 640743965.5172414
Inventory turnover: 9.69141556662535
Receivables turnover: 65.37240510297096
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -10.670148237469899
FCF margin (%): 0.7124332941613637
Revenue growth (%): -22.805895031007502
Rule of 40 score: -22.093461736846137
Financial ratios for 1381.T — annual report dated 2021-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 25.68255834991858
Shares outstanding: 5615670
Market cap (USD): 144224772.44888726
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 1381.T — annual report dated 2022-06-30
Total revenue: 159052639.2854528
Gross profit: 45530419.503623985
Operating income: 17966176.147594992
Net income: 14225053.078556264
Capital expenditures: 22746906.80137638
Operating cash flow: 14840032.213192767
Depreciation & amortization: 7980086.389926055
Net tangible assets: 137418551.87056154
Owner earnings: -541767.3328940608
Return on net tangible assets (%): -0.3942461374533818
Capex to operating income (%): 126.60961695191524
Buffett classification: The Gruesome
Stock price: 20.641701442272492
P/E ratio: 8.148790932321152
Shares outstanding: 5615670
Book value: 137425873.05073577
P/B ratio: 0.8434873358638324
Market cap (USD): 115916983.53832637
Debt to equity: 0.008790155026370466
Current ratio: 4.996821071752952
Quick ratio: 4.180744777475022
Effective tax rate (%): 27.037176117161092
Interest coverage ratio: 613.5
COGS to revenue (%): 71.37399309551208
Free cash flow (dilution-adjusted): -7906874.588183615
Buyback yield (%): 0
Retained earnings: 130148619.95753714
Inventory turnover: 8.628825820812464
Receivables turnover: 11.326903023983316
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 12.777257107154016
FCF margin (%): -4.971231300345225
Rule of 40 score: -4.971231300345225
Financial ratios for 1381.T — annual report dated 2023-06-30
Total revenue: 166466362.7572869
Gross profit: 41504351.429755494
Operating income: 13206243.956347562
Net income: 9738914.214670535
Capital expenditures: 14684348.666942948
Operating cash flow: 18200027.628125433
Depreciation & amortization: 10913109.545517337
Net tangible assets: 136358613.0681033
Owner earnings: 5967675.093244923
Return on net tangible assets (%): 4.376456286090569
Capex to operating income (%): 111.19246861924685
Buffett classification: The Gruesome
Stock price: 18.950821936731593
P/E ratio: 10.927456580851063
Shares outstanding: 5615670
Book value: 136406962.28760877
P/B ratio: 0.7801769091599576
Market cap (USD): 106421562.22544551
Debt to equity: 0.006886424629095145
Current ratio: 4.90777730556736
Quick ratio: 4.057798555036124
Effective tax rate (%): 26.356993736951985
Interest coverage ratio: 318.6666666666667
COGS to revenue (%): 75.06742458819137
Free cash flow (dilution-adjusted): 3460422.7103191046
Buyback yield (%): 0
Retained earnings: 128843762.9506838
Inventory turnover: 9.046
Receivables turnover: 10.08410041841004
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.42661342010551
FCF margin (%): 2.07875191900751
Revenue growth (%): 4.661176013890995
Rule of 40 score: 6.739927932898505
Financial ratios for 1381.T — annual report dated 2024-06-30
Total revenue: 160781629.22397164
Gross profit: 36872238.471591264
Operating income: 9770365.29964528
Net income: 7710498.475325161
Capital expenditures: 13404692.264608875
Operating cash flow: 23206173.37731035
Depreciation & amortization: 10946543.033169458
Net tangible assets: 128869251.35353787
Owner earnings: 5252349.243885744
Return on net tangible assets (%): 4.0757195286845675
Capex to operating income (%): 137.19745222929936
Buffett classification: The Gruesome
Stock price: 17.300080901113944
P/E ratio: 12.599904613801451
Shares outstanding: 5615670
Book value: 128956375.63009523
P/B ratio: 0.753367523236174
Market cap (USD): 97151545.31395854
Debt to equity: 0.004536241675513946
Current ratio: 3.8134845620667925
Quick ratio: 3.2466918714555764
Effective tax rate (%): 29.118993135011443
Interest coverage ratio: 392.50000000000006
COGS to revenue (%): 77.06301285028641
Free cash flow (dilution-adjusted): 9764142.13703404
Buyback yield (%): 0
Retained earnings: 120430642.85269774
Inventory turnover: 11.067259588660367
Receivables turnover: 10.309656823623305
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.378859801663768
FCF margin (%): 6.072921504876915
Revenue growth (%): -3.414944280126903
Rule of 40 score: 2.657977224750012
Financial ratios for 1381.T — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 18.366017649530747
Shares outstanding: 5615670
Market cap (USD): 103137494.33394033
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 1381.T — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 131759984.71240206
Buffett classification: The Gruesome
Stock price: 15.617723443339457
Shares outstanding: 5615670
Market cap (USD): 87703981.00905809
Quick ratio: 0
Buyback yield (%): 0
Retained earnings: 125065290.7828524
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 1381.T — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 149266537.50345972
Buffett classification: The Gruesome
Stock price: 19.4948104068641
Shares outstanding: 5615670
Book value: 149453362.85635203
P/B ratio: 0.7325122691467199
Market cap (USD): 109476421.95751452
Debt to equity: 0.003194592342238067
Current ratio: 4.441765704584041
Quick ratio: 3.6940577249575552
Buyback yield (%): 0
Retained earnings: 141980348.74065873
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 1381.T — annual report dated 2025-06-30
Total revenue: 182853584.2789925
Gross profit: 46104345.41931912
Operating income: 14676169.388319954
Net income: 11901466.92499308
Capital expenditures: 14018820.924439523
Operating cash flow: 20170218.654857457
Depreciation & amortization: 12254359.258234154
Net tangible assets: 149266537.50345972
Owner earnings: 10137005.25878771
Return on net tangible assets (%): 6.791210828852215
Capex to operating income (%): 95.52098066949553
Buffett classification: The Gruesome
Stock price: 19.4948104068641
P/E ratio: 9.198565407732557
Shares outstanding: 5615670
Book value: 149453362.85635203
P/B ratio: 0.7325122691467199
Market cap (USD): 109476421.95751452
Debt to equity: 0.003194592342238067
Current ratio: 4.441765704584041
Quick ratio: 3.6940577249575552
Effective tax rate (%): 32.08366219415943
Interest coverage ratio: 1060.5
COGS to revenue (%): 74.78241126163627
Free cash flow (dilution-adjusted): 6019928.037641848
Buyback yield (%): 0
Retained earnings: 141980348.74065873
Inventory turnover: 8.974568574023614
Receivables turnover: 10.49067090115125
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.584274740171713
FCF margin (%): 3.292212215242565
Revenue growth (%): 13.727908568630218
Rule of 40 score: 17.020120783872784
Financial ratios for 1381.T — quarterly report dated 2025-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 19.871736204576045
Shares outstanding: 5615670
Market cap (USD): 111593112.85195155
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 1737.HK — annual report dated 2022-03-31
Total revenue: 66436526.18135377
Gross profit: 10143678.16091954
Operating income: 3990932.311621967
Net income: 4153001.2771392083
Capital expenditures: 922094.5083014049
Operating cash flow: 11540996.168582376
Depreciation & amortization: 5887228.607918263
Net tangible assets: 28357471.264367815
Owner earnings: 9118135.376756066
Return on net tangible assets (%): 32.1542611883498
Capex to operating income (%): 23.104739351659255
Buffett classification: The Great
Stock price: 0.017879948914431676
P/E ratio: 4.30530782950981
Shares outstanding: 1000000000
Book value: 28468454.66155811
P/B ratio: 0.6280618012812461
Market cap (USD): 17879948.914431676
Debt to equity: 0.16569616164516301
Current ratio: 3.194812479666132
Quick ratio: 3.194812479666132
Effective tax rate (%): 16.656841889432812
Interest coverage ratio: 11.959050899349407
COGS to revenue (%): 84.73177520867054
SG&A to revenue (%): 9.596922710198807
Free cash flow (dilution-adjusted): 10618901.66028097
Buyback yield (%): 0
Retained earnings: 14659897.828863345
Receivables turnover: 3.8589783534368927
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 13.760441757341704
FCF margin (%): 15.9835293484404
Rule of 40 score: 15.9835293484404
Financial ratios for 1737.HK — annual report dated 2023-03-31
Total revenue: 64771464.968152866
Gross profit: 5841019.108280255
Operating income: 499235.66878980893
Net income: 1093757.9617834396
Capital expenditures: 936942.6751592357
Operating cash flow: 6958216.560509554
Depreciation & amortization: 7353248.407643313
Net tangible assets: 26194267.515923567
Owner earnings: 7510063.694267516
Return on net tangible assets (%): 28.67063829787234
Capex to operating income (%): 187.67542740495026
Buffett classification: The Gruesome
Stock price: 0.015286624203821656
P/E ratio: 13.976240391334729
Shares outstanding: 1000000000
Book value: 26304968.152866244
P/B ratio: 0.5811306866059062
Market cap (USD): 15286624.203821655
Debt to equity: 0.2912578573711585
Current ratio: 2.274447324836178
Quick ratio: 2.274447324836178
Effective tax rate (%): -0.33890382143274506
Interest coverage ratio: 2.1556655665566558
COGS to revenue (%): 90.98211054643865
SG&A to revenue (%): 6.244788142926822
Free cash flow (dilution-adjusted): 6007261.146496816
Buyback yield (%): 0
Retained earnings: 12531592.356687898
Receivables turnover: 3.540286868124216
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.7968492095514068
FCF margin (%): 9.27454883018393
Revenue growth (%): -2.506243641721629
Rule of 40 score: 6.768305188462301
Financial ratios for 1737.HK — annual report dated 2024-03-31
Total revenue: 82959131.54533844
Gross profit: 9467560.66411239
Operating income: 2824265.6449553003
Net income: 2251724.1379310344
Capital expenditures: 348786.717752235
Operating cash flow: 7000255.4278416345
Depreciation & amortization: 7205747.126436781
Net tangible assets: 28512899.106002554
Owner earnings: 9108684.54661558
Return on net tangible assets (%): 31.945837961801693
Capex to operating income (%): 12.34964276024238
Buffett classification: The Great
Stock price: 0.010230179028132991
P/E ratio: 4.543264805755847
Shares outstanding: 1000000000
Book value: 28623882.50319285
P/B ratio: 0.3574001195327666
Market cap (USD): 10230179.028132992
Debt to equity: 0.0491734523145566
Current ratio: 3.44330008023856
Quick ratio: 3.44330008023856
Effective tax rate (%): 17.888412816691506
Interest coverage ratio: 20.961137440758293
COGS to revenue (%): 88.58768108133073
SG&A to revenue (%): 4.967593946764783
Free cash flow (dilution-adjusted): 6651468.7100893995
Buyback yield (%): 0
Retained earnings: 14815325.670498084
Receivables turnover: 3.9039004747881485
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.748463715472171
FCF margin (%): 8.017765598780732
Revenue growth (%): 28.07975176434278
Rule of 40 score: 36.097517363123515
Financial ratios for 1737.HK — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 26168082.36808237
Buffett classification: The Gruesome
Stock price: 0.014157014157014158
Shares outstanding: 1000000000
Book value: 26279922.779922783
P/B ratio: 0.5387007517324126
Market cap (USD): 14157014.157014158
Debt to equity: 0.31798036190895956
Current ratio: 2.3801779127793448
Quick ratio: 2.3801779127793448
Buyback yield (%): 0
Retained earnings: 12364736.164736165
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 1737.HK — annual report dated 2025-03-31
Total revenue: 71156041.1311054
Gross profit: 5040359.897172236
Operating income: -2192159.383033419
Net income: -2545115.681233933
Capital expenditures: 2622107.969151671
Operating cash flow: 9367480.719794344
Depreciation & amortization: 6313496.143958868
Net tangible assets: 23580334.19023136
Owner earnings: 1146272.4935732642
Buffett classification: The Gruesome
Stock price: 0.016709511568123392
Shares outstanding: 1000000000
Book value: 23692030.84832905
P/B ratio: 0.7052798333369501
Market cap (USD): 16709511.568123393
Debt to equity: 0.38792018402378414
Current ratio: 2.4428636739669964
Quick ratio: 2.4428636739669964
Interest coverage ratio: -5.478637969804048
COGS to revenue (%): 92.91646947040611
SG&A to revenue (%): 6.463220338370719
Free cash flow (dilution-adjusted): 6723007.712082262
Buyback yield (%): 0
Retained earnings: 9794730.077120822
Receivables turnover: 4.750534183450181
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -7.476557670978858
FCF margin (%): 9.448259916111807
Revenue growth (%): -14.227596401226156
Rule of 40 score: -4.779336485114349
Financial ratios for 1737.HK — quarterly report dated 2025-03-31
Capital expenditures: 0
Net tangible assets: 23580334.19023136
Buffett classification: The Gruesome
Stock price: 0.016709511568123392
Shares outstanding: 1000000000
Book value: 23692030.84832905
P/B ratio: 0.7052798333369501
Market cap (USD): 16709511.568123393
Debt to equity: 0.38792018402378414
Current ratio: 2.4428636739669964
Quick ratio: 2.4428636739669964
Buyback yield (%): 0
Retained earnings: 9794730.077120822
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 1832.HK — annual report dated 2021-12-31
Total revenue: 2538589.7435897435
Gross profit: 1263846.153846154
Operating income: -807948.717948718
Net income: -763076.9230769231
Capital expenditures: 6162948.717948718
Operating cash flow: 296025.64102564106
Depreciation & amortization: 581794.8717948718
Net tangible assets: 11004615.384615384
Owner earnings: -6344230.769230769
Return on net tangible assets (%): -57.65063609674262
Buffett classification: The Gruesome
Stock price: 0.11282051282051282
Shares outstanding: 360000000
Book value: 10983461.53846154
P/B ratio: 3.6978674230486392
Market cap (USD): 40615384.615384616
Debt to equity: 0.4353748643064747
Current ratio: 0.83671327592061
Quick ratio: 0.757631879495015
Interest coverage ratio: -6.4503582395087005
COGS to revenue (%): 50.21463562446341
SG&A to revenue (%): 5.86334023534165
Free cash flow (dilution-adjusted): -5879871.794871795
Buyback yield (%): 0
Retained earnings: 1989615.3846153847
Inventory turnover: 3.8809523809523805
Receivables turnover: 1.5289166859701953
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -6.034606582336662
FCF margin (%): -231.61961517095096
Rule of 40 score: -231.61961517095096
Financial ratios for 1832.HK — annual report dated 2022-12-31
Total revenue: 2021951.219512195
Gross profit: 404364.56996148906
Operating income: -1601283.6970474967
Net income: -1466623.8767650835
Capital expenditures: 4123876.76508344
Operating cash flow: -922721.4377406932
Depreciation & amortization: 552759.9486521181
Net tangible assets: 9558151.476251604
Owner earnings: -5037740.693196406
Return on net tangible assets (%): -52.706223642859065
Buffett classification: The Gruesome
Stock price: 0.10911424903722722
Shares outstanding: 360000000
Book value: 9522079.589216944
P/B ratio: 4.125267940197097
Market cap (USD): 39281129.6534018
Debt to equity: 0.9923021960985212
Current ratio: 0.28388813684469605
Quick ratio: 0.2618139305931578
Interest coverage ratio: -9.457164518574677
COGS to revenue (%): 80.00126976065012
SG&A to revenue (%): 24.728588661037396
Free cash flow (dilution-adjusted): -5046854.942233633
Buyback yield (%): 0
Retained earnings: 525545.5712451861
Inventory turnover: 8.781184668989546
Receivables turnover: 1.6982210242587599
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -13.341176470588238
FCF margin (%): -249.60319979683834
Revenue growth (%): -20.351398857658086
Rule of 40 score: -269.9545986544964
Financial ratios for 1832.HK — annual report dated 2023-12-31
Total revenue: 4717925.736235595
Gross profit: 1687836.1075544176
Operating income: -2336107.5544174137
Net income: -2939948.7836107556
Capital expenditures: 1166709.3469910373
Operating cash flow: -392573.6235595391
Depreciation & amortization: 1391165.1728553139
Net tangible assets: 6595646.606914213
Owner earnings: -2715492.9577464787
Return on net tangible assets (%): -41.170989284050314
Buffett classification: The Gruesome
Stock price: 0.0768245838668374
Shares outstanding: 360000000
Book value: 6556466.069142126
P/B ratio: 4.218255673163302
Market cap (USD): 27656850.19206146
Debt to equity: 1.7869976174667033
Current ratio: 0.277403108628325
Quick ratio: 0.2320906538539466
Interest coverage ratio: -3.734138354482194
COGS to revenue (%): 64.22503867343339
Free cash flow (dilution-adjusted): -1559667.0934699106
Buyback yield (%): 0
Retained earnings: -2415749.039692702
Inventory turnover: 7.558288086873204
Receivables turnover: 6.604588635956264
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -20.68007934258997
FCF margin (%): -33.05832225147231
Revenue growth (%): 133.3352897293841
Rule of 40 score: 100.2769674779118
Financial ratios for 1832.HK — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 4434664.948453608
Buffett classification: The Gruesome
Stock price: 0.06958762886597938
Shares outstanding: 360000000
Book value: 4378608.247422682
P/B ratio: 5.72134910824651
Market cap (USD): 25051546.39175258
Debt to equity: 2.7654070280769902
Current ratio: 0.24005583896318763
Quick ratio: 0.1781676547635461
Buyback yield (%): 0
Retained earnings: -4873969.072164949
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 1832.HK — annual report dated 2024-12-31
Total revenue: 5514819.587628867
Gross profit: 2733505.154639175
Operating income: -1402835.0515463918
Net income: -2442654.6391752576
Capital expenditures: 351288.65979381447
Operating cash flow: 226030.92783505155
Depreciation & amortization: 1437113.4020618557
Net tangible assets: 4434664.948453608
Owner earnings: -1356829.8969072164
Return on net tangible assets (%): -30.59599569929968
Buffett classification: The Gruesome
Stock price: 0.06958762886597938
Shares outstanding: 360000000
Book value: 4378608.247422682
P/B ratio: 5.72134910824651
Market cap (USD): 25051546.39175258
Debt to equity: 2.7654070280769902
Current ratio: 0.24005583896318763
Quick ratio: 0.1781676547635461
Interest coverage ratio: -2.3501727115716755
COGS to revenue (%): 50.43346185302021
SG&A to revenue (%): 0.5187521906764808
Free cash flow (dilution-adjusted): -127061.85567010309
Buyback yield (%): 0
Retained earnings: -4873969.072164949
Inventory turnover: 6.010303536619326
Receivables turnover: 22.488176563321073
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -13.261054939700328
FCF margin (%): -2.3040074775090544
Revenue growth (%): 16.890767170682683
Rule of 40 score: 14.586759693173628
Financial ratios for 1832.HK — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 3163566.878980892
Buffett classification: The Gruesome
Stock price: 0.05605095541401274
Shares outstanding: 360000000
Book value: 3090318.471337581
P/B ratio: 6.5295354301496324
Market cap (USD): 20178343.949044585
Debt to equity: 4.028814048394409
Current ratio: 0.2098611827020494
Quick ratio: 0.1527168020475996
Buyback yield (%): 0
Retained earnings: -6039745.222929937
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 1932.HK — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.05897435897435898
Shares outstanding: 1000000000
Market cap (USD): 58974358.97435898
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 1932.HK — annual report dated 2022-12-31
Total revenue: 82548010.26957639
Gross profit: 18296277.27856226
Operating income: -4821437.740693197
Net income: -12591014.120667523
Capital expenditures: 2707188.703465982
Operating cash flow: -4766752.246469833
Depreciation & amortization: 4220282.413350449
Net tangible assets: 66503979.460847236
Owner earnings: -11077920.410783056
Return on net tangible assets (%): -16.657530121644733
Buffett classification: The Gruesome
Stock price: 0.04621309370988447
Shares outstanding: 1000000000
Book value: 66873555.840821564
P/B ratio: 0.6910518384858286
Market cap (USD): 46213093.709884465
Debt to equity: 0.4722283542408508
Current ratio: 1.122882062202145
Quick ratio: 1.0495361882051997
Interest coverage ratio: -5.053006861294229
COGS to revenue (%): 77.83559262202414
SG&A to revenue (%): 33.34271571839782
Free cash flow (dilution-adjusted): -8277150.192554557
Buyback yield (%): 0
Retained earnings: 21964313.22207959
Inventory turnover: 11.606553195436417
Receivables turnover: 2.1059958996797037
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -6.649046342750117
FCF margin (%): -10.027074142094925
Rule of 40 score: -10.027074142094925
Financial ratios for 1932.HK — annual report dated 2023-12-31
Total revenue: 60062868.117797695
Gross profit: 20171959.026888605
Operating income: 1156722.1510883484
Net income: -8575800.256081946
Capital expenditures: 329321.3828425096
Operating cash flow: 10708962.868117798
Depreciation & amortization: 2973367.47759283
Net tangible assets: 56909731.11395647
Owner earnings: -5931754.161331627
Return on net tangible assets (%): -10.423092931951897
Capex to operating income (%): 28.470223599734336
Buffett classification: The Good
Stock price: 0.03329065300896287
Shares outstanding: 1000000000
Book value: 57444302.17669654
P/B ratio: 0.5795292439372326
Market cap (USD): 33290653.00896287
Debt to equity: 0.4970377139800286
Current ratio: 1.3013552835085327
Quick ratio: 1.229651086586101
Interest coverage ratio: 0.6822232291194684
COGS to revenue (%): 66.41525844665534
SG&A to revenue (%): 32.70623397166008
Free cash flow (dilution-adjusted): 9982842.509603074
Buyback yield (%): 0
Retained earnings: 13314596.6709347
Inventory turnover: 11.389902387306693
Receivables turnover: 3.018040391432744
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.527590131030506
FCF margin (%): 16.62065569367138
Revenue growth (%): -27.23886630137921
Rule of 40 score: -10.61821060770783
Financial ratios for 1932.HK — annual report dated 2024-12-31
Total revenue: 41411340.20618557
Gross profit: 16664690.721649485
Operating income: -2990077.319587629
Net income: -6174613.402061855
Capital expenditures: 83891.7525773196
Operating cash flow: -3285051.5463917525
Depreciation & amortization: 2251417.525773196
Net tangible assets: 48593814.432989694
Owner earnings: -4007087.628865979
Return on net tangible assets (%): -8.246085794297352
Buffett classification: The Gruesome
Stock price: 0.03221649484536083
Shares outstanding: 1000000000
Book value: 49106056.701030925
P/B ratio: 0.6560594967236391
Market cap (USD): 32216494.845360827
Debt to equity: 0.5303217578195731
Current ratio: 1.3517144664932528
Quick ratio: 1.2826547867046056
Interest coverage ratio: -2.0761453113815316
COGS to revenue (%): 59.758146829644744
SG&A to revenue (%): 40.570464786277974
Free cash flow (dilution-adjusted): -3434536.082474227
Buyback yield (%): 0
Retained earnings: 7320489.69072165
Inventory turnover: 10.289005572224603
Receivables turnover: 3.1598654840803166
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -4.347272158385122
FCF margin (%): -8.29370907914063
Revenue growth (%): -31.053342099867763
Rule of 40 score: -39.34705117900839
Financial ratios for 1932.HK — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 48593814.432989694
Buffett classification: The Gruesome
Stock price: 0.03221649484536083
Shares outstanding: 1000000000
Book value: 49106056.701030925
P/B ratio: 0.6560594967236391
Market cap (USD): 32216494.845360827
Debt to equity: 0.5303217578195731
Current ratio: 1.3517144664932528
Quick ratio: 1.2826547867046056
Buyback yield (%): 0
Retained earnings: 7320489.69072165
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 1932.HK — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 46217197.4522293
Buffett classification: The Gruesome
Stock price: 0.021656050955414015
Shares outstanding: 1000000000
Book value: 46734522.292993635
P/B ratio: 0.4633844509984572
Market cap (USD): 21656050.955414016
Debt to equity: 0.45023250996276565
Current ratio: 1.265289799055377
Quick ratio: 1.1743933009522192
Buyback yield (%): 0
Retained earnings: 3630318.4713375797
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 2507.HK — annual report dated 2024-12-31
Total revenue: 1197133000
Gross profit: 413550000
Operating income: 148741000
Net income: 120746000
Capital expenditures: 52704000
Operating cash flow: 164535000
Depreciation & amortization: 44976000
Net tangible assets: 400327000
Owner earnings: 113018000
Return on net tangible assets (%): 28.231420813484974
Capex to operating income (%): 35.43340437404616
Buffett classification: The Good
Stock price: 2.506443298969072
P/E ratio: 7.597189309573081
Shares outstanding: 365988818
Book value: 781951000
P/B ratio: 1.1731300559417552
Market cap (USD): 917330220.3737113
Debt to equity: 0.08996087990168182
Current ratio: 1.6150336804796064
Quick ratio: 1.2415062249739974
Effective tax rate (%): 18.20706660163659
Interest coverage ratio: 28.909815354713313
COGS to revenue (%): 65.45496615664258
SG&A to revenue (%): 22.120265668058604
Free cash flow (dilution-adjusted): 70183000
Buyback yield (%): 0
Retained earnings: 552118000
Inventory turnover: 4.682216631909795
Receivables turnover: 104.87367498904949
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 16.252525440155946
FCF margin (%): 5.862590038032533
Revenue growth (%): 12.12175988191528
Rule of 40 score: 17.98434991994781
Financial ratios for 2507.HK — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 400327000
Buffett classification: The Gruesome
Stock price: 2.506443298969072
Shares outstanding: 365988818
Book value: 781951000
P/B ratio: 1.1731300559417552
Market cap (USD): 917330220.3737113
Debt to equity: 0.08996087990168182
Current ratio: 1.6150336804796064
Quick ratio: 1.2415062249739974
Buyback yield (%): 0
Retained earnings: 552118000
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 2507.HK — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 417892000
Buffett classification: The Gruesome
Stock price: 5.336305732484076
Shares outstanding: 365988818
Book value: 810321000
P/B ratio: 2.4101908102078946
Market cap (USD): 1953028227.5184712
Debt to equity: 0.07812829730440159
Current ratio: 1.5401421096905445
Quick ratio: 1.0474633638990476
Buyback yield (%): 0
Retained earnings: 617084000
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 2866.HK — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.12179487179487179
Shares outstanding: 3445672000
Market cap (USD): 419665179.48717946
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0